Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 11152-11159
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11152
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11152
Table 1 Characteristics of patients and controls
Features | Patients (n = 120) | Controls (n = 11) |
Male/female | 57/63 | 4/7 |
Age (yr) | 51.33 ± 7.33 | 38.45 ± 6.95 |
BMI (kg/m2) | 22.34 ± 2.73 | 24.00 ± 2.53 |
ALT (U/L) | 60.42 ± 70.88 | 16.71 ± 5.14 |
AST (U/L) | 47.94 ± 44.30 | 19.87 ± 3.49 |
TBIL (µmol/L) | 16.51 ± 7.25 | 16.30 ± 5.64 |
DBIL (µmol/L) | 3.26 ± 1.36 | 2.82 ± 0.75 |
TP (g/L) | 70.93 ± 4.95 | 69.05 ± 3.15 |
ALB (g/L) | 43.24 ± 2.36 | 43.86 ± 2.18 |
GGT (U/L) | 22.04 ± 16.50 | 15.90 ± 10.82 |
CHE (U/L) | 6657.09 ± 1442.44 | 7703.45 ± 945.75 |
Ca (mmol/L) | 2.26 ± 0.08 | 2.21 ± 0.05 |
P (mmol/L) | 0.92 ± 0.19 | 1.02 ± 0.14 |
HB (g/L) | 151.09 ± 16.56 | 144.45 ± 11.43 |
PLT (× 109/L) | 171.36 ± 53.20 | 242.18 ± 48.36 |
PTA (%) | 92.41 ± 9.11 | 93.78 ± 4.69 |
Virus load, n (%) | ||
< 4 log10 | 20 (16.7) | |
4-5 log10 | 52 (43.3) | |
6-7 log10 | 48 (40.0) | |
Stage of fibrosis, n (%) | ||
0 | 1 (0.8) | |
1 | 55 (45.8) | |
2 | 50 (47.1) | |
3 | 12 (10) | |
4 | 2 (1.7) | |
Grade of inflammation, n (%) | ||
0 | 1 (0.8) | |
1 | 16 (13.3) | |
2 | 67 (55.8) | |
3 | 34 (28.3) | |
4 | 2 (1.7) |
Table 2 Serum 25(OH)D3 and 24,25(OH)2D3 levels, and the 25(OH)D3/24,25(OH)2D3 ratio, in chronic hepatitis C patients and healthy controls
Patients(n = 120) | Controls(n = 11) | P value | |
25(OH)D3 (ng/mL) | 5.84 ± 2.63 | 10.08 ± 3.15 | < 0.001 |
24,25(OH)2D3 (ng/mL) | 1.78 ± 1.02 | 2.30 ± 1.27 | 0.161 |
25(OH)D3/24,25(OH)2D3 | 4.10 ± 2.44 | 5.52 ± 2.47 | 0.076 |
Table 3 Correlations of serum 25(OH)D3 and 24,25(OH)2D3 levels, and the 25(OH)D3/24, 25(OH)2D3 ratio, with clinical parameters
25(OH)D3 (ng/mL) | 24,25(OH)2D3 (ng/mL) | 25(OH)D3/24,25(OH)2D3 | ||||
r value | P value | r value | P value | r value | P value | |
Age (yr) | -0.034 | 0.711 | -0.132 | 0.150 | -0.134 | 0.145 |
ALT (U/L) | -0.062 | 0.502 | 0.175 | 0.055 | -0.230 | 0.012 |
AST (U/L) | 0.036 | 0.693 | 0.169 | 0.066 | -0.149 | 0.104 |
TBIL (μmol/L) | -0.124 | 0.177 | 0.088 | 0.337 | -0.176 | 0.054 |
DBIL (μmol/L) | -0.165 | 0.072 | 0.109 | 0.065 | -0.282 | 0.002 |
TP (g/L) | -0.126 | 0.170 | 0.136 | 0.138 | -0.185 | 0.043 |
ALB (g/L) | 0.027 | 0.770 | 0.120 | 0.193 | -0.112 | 0.223 |
GGT (U/L) | -0.143 | 0.119 | 0.104 | 0.260 | -0.211 | 0.021 |
CHE (U/L) | -0.015 | 0.871 | -0.058 | 0.526 | -0.011 | 0.906 |
Ca (mmol/L) | 0.027 | 0.768 | 0.200 | 0.028 | -0.158 | 0.084 |
P (mmol/L) | 0.088 | 0.337 | -0.130 | 0.158 | 0.266 | 0.003 |
HB (g/L) | -0.040 | 0.665 | 0.133 | 0.149 | -0.195 | 0.033 |
PTA (%) | 0.109 | 0.237 | -0.134 | 0.145 | 0.231 | 0.011 |
Liver fibrosis | -0.052 | 0.574 | 0.023 | 0.807 | -0.072 | 0.435 |
Liver inflammation | -0.104 | 0.258 | -0.129 | 0.160 | 0.069 | 0.451 |
Viral load( IU/mL) | 0.074 | 0.464 | 0.173 | 0.086 | -0.131 | 0.196 |
25(OH)D3 (ng/mL) | - | - | 0.410 | < 0.001 | - | - |
24,25(OH)2D3 (ng/mL) | 0.410 | < 0.001 | - | - | - | - |
- Citation: Ren Y, Liu M, Zhao J, Ren F, Chen Y, Li JF, Zhang JY, Qu F, Zhang JL, Duan ZP, Zheng SJ. Serum vitamin D3 does not correlate with liver fibrosis in chronic hepatitis C. World J Gastroenterol 2015; 21(39): 11152-11159
- URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11152.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i39.11152